Skip to content

The clinical effect and mechanism of constraint-induced movement therapy combined with repetitive transcranial magnetic stimulation on upper limb dysfunction after stroke

The clinical effect and mechanism of constraint-induced movement therapy combined with repetitive transcranial magnetic stimulation on upper limb dysfunction after stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036803
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

A:CIMT+rTMS
B:CIMT
C:rTMS
D:Routine rehabilitation

Sponsors

Huashan Hospital North, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged 30-75 years old; (2) It meets the diagnostic criteria of "Stroke" formulated by the Fourth National Cerebrovascular Disease Academic Conference and is clearly diagnosed by CT or MRI, the course of the disease is more than 2 weeks, and the vital signs are stable within 6 months; (3) Unilateral lesions, which are located in the nucleus basalis area of the inner capsule, involving white matter but no gray matter; (4) The wrist of the affected side can actively extend back at least 10°, and the other two fingers except the thumb can extend back at least 10 degree; (5) The modified Ashworth classification of the affected upper limb <=1+; (6) Able to walk independently and have sufficient balance; (7) No cognitive impairment, able to cooperate with treatment and evaluation; (8) Willing to obey guidance and have a good desire for recovery and good family support; (9) Patient and his/her family members willing to sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients who have previously suffered from Parkinson's disease, peripheral neuropathy and other motor dysfunctions; (2) Those who have severe cognitive, speech, vision, hearing, or mental disorders that affect inspection and treatment; (3) Patients who have not had a stroke for the first time or who have had a lacunar infarction in the past and have sequelae; (4) Patients with tumors, severe respiratory, heart, liver, kidney, endocrine and hematopoietic diseases; (5) Those who have a history of epilepsy or a family history of epilepsy, have a metal pacemaker in their body, have metal implants in the brain, cochlear implants, etc. who are not suitable for transcranial magnetic stimulation treatment; (6) Those who have a history of alcohol or drug abuse; (7) Pregnant and lactating women; (8) Those who are participating in other clinical trials that affect the evaluation of the results of this study; (9) Those who cannot complete the basic course of treatment, who may have poor compliance (that is, who cannot adhere to treatment) and who are difficult to follow up.

Design outcomes

Primary

MeasureTime frame
ARAT;WMFT;

Secondary

MeasureTime frame
FMA;FIM;MT;CMCT;

Countries

China

Contacts

Public ContactWang Yuyuan

Huashan Hospital North, Fudan University

wangyuyuan1220@163.com+86 13818915325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026